Frontiers in Pharmacology, 2025 · DOI: 10.3389/fphar.2025.1510372 · Published: January 29, 2025
Spinal cord injury (SCI) often leads to inflammation and nerve damage, causing loss of movement and sensation. This study explores how zinc ions, known for their potential in reducing inflammation and promoting cell survival, can help in SCI. The research shows that zinc ions work by increasing the expression of IKBα, a protein that reduces inflammation. This reduces inflammation, cell polarization, and cell death in SCI models. These findings suggest that zinc ions could be a potential treatment for SCI and other inflammatory conditions. Further research is needed to explore the clinical benefits of zinc ions.
Zinc ions may be a viable therapeutic approach for managing inflammation and promoting neuronal repair in spinal cord injury.
The findings provide a foundation for developing new therapeutic strategies targeting the IKBα pathway for SCI treatment.
Further clinical investigations into the benefits of zinc ions are warranted to improve the quality of life for SCI patients.